Verweij J - Search Results

1

Disposition of polyoxyethylated excipients in humans: implications for drug safety and formulation approaches.

Ten Tije AJ, Loos WJ, Verweij J, Baker SD, Dinh K, Figg WD, Sparreboom A. Ten Tije AJ, et al. Among authors: verweij j. Clin Pharmacol Ther. 2003 Nov;74(5):509-10. doi: 10.1016/j.clpt.2003.08.004. Clin Pharmacol Ther. 2003. PMID: 14586392 Clinical Trial. No abstract available.

2

Clinical pharmacokinetics of unbound docetaxel: role of polysorbate 80 and serum proteins.

Loos WJ, Baker SD, Verweij J, Boonstra JG, Sparreboom A. Loos WJ, et al. Among authors: verweij j. Clin Pharmacol Ther. 2003 Oct;74(4):364-71. doi: 10.1016/S0009-9236(03)00222-4. Clin Pharmacol Ther. 2003. PMID: 14534523

3

Effect of cytochrome P450 3A4 inhibition on the pharmacokinetics of docetaxel.

Engels FK, Ten Tije AJ, Baker SD, Lee CK, Loos WJ, Vulto AG, Verweij J, Sparreboom A. Engels FK, et al. Among authors: verweij j. Clin Pharmacol Ther. 2004 May;75(5):448-54. doi: 10.1016/j.clpt.2004.01.001. Clin Pharmacol Ther. 2004. PMID: 15116057 Clinical Trial.

4

Relationship of systemic exposure to unbound docetaxel and neutropenia.

Baker SD, Li J, ten Tije AJ, Figg WD, Graveland W, Verweij J, Sparreboom A. Baker SD, et al. Among authors: verweij j. Clin Pharmacol Ther. 2005 Jan;77(1):43-53. doi: 10.1016/j.clpt.2004.09.005. Clin Pharmacol Ther. 2005. PMID: 15637530

5

Clinical pharmacokinetics of irinotecan and its metabolites in relation with diarrhea.

Xie R, Mathijssen RH, Sparreboom A, Verweij J, Karlsson MO. Xie R, et al. Among authors: verweij j. Clin Pharmacol Ther. 2002 Sep;72(3):265-75. doi: 10.1067/mcp.2002.126741. Clin Pharmacol Ther. 2002. PMID: 12235447

6

Pharmacological effects of formulation vehicles : implications for cancer chemotherapy.

ten Tije AJ, Verweij J, Loos WJ, Sparreboom A. ten Tije AJ, et al. Among authors: verweij j. Clin Pharmacokinet. 2003;42(7):665-85. doi: 10.2165/00003088-200342070-00005. Clin Pharmacokinet. 2003. PMID: 12844327 Review.

7

Influence of genetic variants in UGT1A1 and UGT1A9 on the in vivo glucuronidation of SN-38.

Paoluzzi L, Singh AS, Price DK, Danesi R, Mathijssen RH, Verweij J, Figg WD, Sparreboom A. Paoluzzi L, et al. Among authors: verweij j. J Clin Pharmacol. 2004 Aug;44(8):854-60. doi: 10.1177/0091270004267159. J Clin Pharmacol. 2004. PMID: 15286088

8

Mechanism-based models for topotecan-induced neutropenia.

Léger F, Loos WJ, Bugat R, Mathijssen RH, Goffinet M, Verweij J, Sparreboom A, Chatelut E. Léger F, et al. Among authors: verweij j. Clin Pharmacol Ther. 2004 Dec;76(6):567-78. doi: 10.1016/j.clpt.2004.08.008. Clin Pharmacol Ther. 2004. PMID: 15592328

9

Association of enzyme and transporter genotypes with the pharmacokinetics of imatinib.

Gardner ER, Burger H, van Schaik RH, van Oosterom AT, de Bruijn EA, Guetens G, Prenen H, de Jong FA, Baker SD, Bates SE, Figg WD, Verweij J, Sparreboom A, Nooter K. Gardner ER, et al. Among authors: verweij j. Clin Pharmacol Ther. 2006 Aug;80(2):192-201. doi: 10.1016/j.clpt.2006.05.003. Clin Pharmacol Ther. 2006. PMID: 16890580

10

Clinical pharmacokinetics of encapsulated oral 9-aminocamptothecin in plasma and saliva.

de Jonge MJ, Verweij J, Loos WJ, Dallaire BK, Sparreboom A. de Jonge MJ, et al. Among authors: verweij j. Clin Pharmacol Ther. 1999 May;65(5):491-9. doi: 10.1016/S0009-9236(99)70068-8. Clin Pharmacol Ther. 1999. PMID: 10340914 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

929 results

Search Page

Filters